The Lancet Haematology in conversation with
Episodes
Julio Delgado and Valentín Ortiz-Maldonado (Spanish version)
04 Mar 2026
Contributed by Lukas
Dr Julio Delgado and Dr Valentín Ortiz-Maldonado join us to discuss the results of their phase 2 trial testing varnimcabtagene autoleucel for adults ...
Julio Delgado and Valentín Ortiz-Maldonado
04 Mar 2026
Contributed by Lukas
Dr Julio Delgado and Dr Valentín Ortiz-Maldonado join us to discuss the results of their phase 2 trial testing varnimcabtagene autoleucel for adults ...
Erica Kaye and Dylan Graetz discuss expert recommendations for the conduct and appraisal of qualitative research in haematology
04 Feb 2026
Contributed by Lukas
Dr Erica Kaye and Dr Dylan Graetz join us to discuss the importance of qualitative research and how the whole research ecosystem can incorporate and s...
Presented at ASH: API-CAT post-hoc analysis on predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated VTE
31 Dec 2025
Contributed by Lukas
Professor Isabelle Mahé joins us to discuss the results of a post-hoc analysis of the API-CAT trial identifying predictors associated with clinically...
Presented at ASH 2025: EPCORE CLL-1 trial on epcoritamab monotherapy for Richter transformation
08 Dec 2025
Contributed by Lukas
Arnon Kater joins Daniela Marin of The Lancet Haematology to discuss the phase 1b/2 EPCORE CLL-1 trial of epcoritamab monotherapy for Richter transfor...
ASH 2025 Preview - Expert Roundtable
02 Dec 2025
Contributed by Lukas
Khaled Musallam, Bethany Samuelson Bannow, Mohamad Mohty, David Sallman, and Anna Sureda join us to share their expectations for the upcoming ASH 2025...
Arnon Kater and Sabina Kersting on the HOVON 158/NEXT STEP phase 2 trial testing a new first-line treatment regimen for chronic lymphocytic leukaemia
01 Dec 2025
Contributed by Lukas
Professor Arnon Kater and Dr Sabina Kersting join us to discuss the results of their phase 2 trial testing a new first-line treatment regimen in chron...
Ruben Mesa on ropeginterferon alfa-2b for hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia
03 Nov 2025
Contributed by Lukas
Dr. Ruben Mesa (Executive Director of the Wake Forest Baptist Comprehensive Cancer Center) joins us to discuss the results of a multicentre, open-labe...
A panel of the authors on our Lancet Haematology-Lancet Regional Health Western Pacific Series on mature T-cell and natural killer-cell lymphomas
14 Sep 2025
Contributed by Lukas
Today, on World Lymphoma Awareness Day, Professors Yok Lam Kwong, Wee Joo Chng, and Eric Tse join us in this joint episode of The Lancet Haematology a...
Lan-Lan Smith, Cheryl Lai, and Daniela Marín discuss the EHA, ICML, and ISTH conferences
04 Aug 2025
Contributed by Lukas
June has been packed with interesting haematology conferences so the editorial team behind The Lancet Haematology have gathered to share their thought...
Paolo Strati on off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy for patients with relapsed or refractory B-cell lymphoma
01 Jul 2025
Contributed by Lukas
Associate Professor Paolo Strati (Department of Lymphoma and Myeloma, and Department of Translational Molecular Pathology, University of Texas MD Ande...
A panel of the authors on our Adverse Events Series on adverse event reporting in haematological malignancies
13 Jun 2025
Contributed by Lukas
With a growing number of treatment options for blood cancers, understanding the side effects from these treatments and how they affect patients is bec...
Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma
28 Apr 2025
Contributed by Lukas
Dr Michael Northend (University College London Hospitals NHS Foundation Trust, and Cancer Research UK & UCL Cancer Trials Centre, London, UK) join...
Joanne Verweij and Romy Pothof on fetal and neonatal alloimmune thrombocytopenia
31 Mar 2025
Contributed by Lukas
Dr Romy Pothof and Prof Joanne Verweij join us to discuss their development of an international consensus on the diagnosis and treatment of fetal and ...
Helene Schoemans, Elke Stienissen, and Kathy Goris on a consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe
03 Mar 2025
Contributed by Lukas
Prof Helene Schoemans, Elke Stienissen, and Kathy Goris join us to discuss the importance of consulting a patient advisory board to understand unmet n...
Dawn Swan on air pollution and venous thromboembolism
29 Jan 2025
Contributed by Lukas
Dr Dawn Swan joins us to discuss current knowledge and future perspectives on the possible association between air pollution and venous thromboembolis...
Leslie Skeith on low-dose aspirin for postpartum venous thromboembolism prophylaxis
16 Jan 2025
Contributed by Lukas
Dr Leslie Skeith joins us to discuss the PARTUM pilot trial, comparing low-dose aspirin versus placebo in postpartum venous thromboembolism.Read the f...
Neema Mayor and Caitlin Farrow on impact of patient ethnicity on haematopoeietic cell transplantation outcome in the United Kingdom
03 Dec 2024
Contributed by Lukas
Dr Neema Mayor and Dr Caitlin Farrow from the Anthony Nolan Research Institute join us to discuss the findings of their study on the impact of patient...
Lancet Haematology 10 year anniversary - meet the editors
02 Oct 2024
Contributed by Lukas
In a special 10 year anniversary podcast, Lan-Lan Smith, Yaiza del Pozo Martin, and Emma Cookson, the editorial team behind The Lancet Haematology, re...
Matteo Della Porta on the phase 3 COMMANDS trial examining luspatercept versus epoetin alfa in patients with lower-risk myleodysplastic syndrome
22 Aug 2024
Contributed by Lukas
Professor Matteo Giovanni Della Porta joins us to discuss the primary analysis of the phase 3 COMMANDS trial comparing luspatercept versus epoetin alf...
Kim Linton on follicular lymphoma
07 Aug 2024
Contributed by Lukas
Dr Kim Linton joins us to discuss the EPCORE NHL-1 trial testing monotherapy with the bispecific antibody epcoritamab for patients with relapsed or re...
Judy Truong on ferritin reference levels and iron deficiency
05 Aug 2024
Contributed by Lukas
Dr Judy Truong join us to discuss ferritin reference intervals and how adoption of evidence-based ferritin clinical decision limits can help clinician...
Johannes Schetelig on remission induction versus immediate allogeneic HSCT for patients with AML
16 Jul 2024
Contributed by Lukas
Professor Johannes Schetelig joins us to discuss the results of the ASAP phase 3 trial comparing remission induction with immediate allogeneic haemato...
Banu Aygun on sickle cell anaemia
23 May 2024
Contributed by Lukas
Professor Banu Aygun joins us to discuss the REACH trial testing hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Af...
Sabine Braat and Katherine Fielding on haemoglobin thresholds to define anaemia
01 Mar 2024
Contributed by Lukas
Dr Sabine Braat and Dr Katherine Fielding join us to discuss their study presenting new haemoglobin thresholds for defining anaemia.Read the full arti...
Elisabeth Schorb on the MARTA phase 2 trial
29 Feb 2024
Contributed by Lukas
Doctor Elisabeth Schorb joins us to discuss the MARTA phase 2 trial, treating older, fit patients with primary diffuse large B-cell CNS lymphoma with ...
Stephan Ehl on paediatric autoimmune lymphoproliferative immunodeficiencies
31 Jan 2024
Contributed by Lukas
Professor Stephan Ehl joins us to discuss a prospective observational study on paediatric autoimmune lymphoproliferative immunodeficiencies.Read the f...
Dr Sarah O'Brien on the PREVAPIX-ALL trial
20 Dec 2023
Contributed by Lukas
Dr Sarah O'Brien joins Lan-Lan Smith to discuss results of the phase 3 PREVAPIX-ALL trial, which compares direct oral anticoagulant apixaban to l...
Enrico Lopriore on haemolytic disease of the fetus and newborn
29 Nov 2023
Contributed by Lukas
Professor Enrico Lopriore joins us to discuss a trial testing darbepoetin alfa to prevent postnatal anaemia in infants with haemolytic disease of the ...
Meletios Dimopoulos on relapsed and refractory multiple myeloma
03 Oct 2023
Contributed by Lukas
Professor Meletios Dimopoulos joins us to discuss two trials for patients with relapsed and refractory multiple myeloma - the first report of the DREA...
Eric Ohuma on haemoglobin concentrations and neonatal outcomes
29 Aug 2023
Contributed by Lukas
Dr Eric Ohuma joins us to tell us about a study recently published in The Lancet Haematology on the association between maternal haemoglobin concentra...
Margaret Ragni on tranexamic acid to treat heavy menstrual bleeding
31 Jul 2023
Contributed by Lukas
Professor Margaret Ragni joins us to discuss the VWDMin study, published in The Lancet Haematology. In this phase 3, randomised, crossover trial, reco...
Oreofe Odejide and Thomas Kuczmarski on mental health and lymphoma
03 Jul 2023
Contributed by Lukas
Dr Odejide and Dr Kuczmarski tell us about a study recently published in The Lancet Haematology on the effect of pre-existing mental health conditions...
Alok Srivastava on fitusiran for patients with haemophilia A and B
29 Mar 2023
Contributed by Lukas
Professor Alok Srivastava tells us about two clinical trials being published in The Lancet and The Lancet Haematology on a new siRNA therapy called fi...
Emmanuela E Ambrose on stroke prevention in children with sickle cell disease
02 Mar 2023
Contributed by Lukas
Dr Emmanuela E Ambrose tells us about the SPHERE trial on hydroxyurea dose escalation for primary stroke prevention in children with sickle cell disea...
Sumit Gupta on racial and ethnic disparities in leukaemia survival outcomes
30 Jan 2023
Contributed by Lukas
Dr Sumit Gupta discusses how racial and ethnic disparities affect survival outcomes of children and young adults with acute lymphocytic leukaemia.Read...
Xiao-Jun Huang on cellular therapy in China
28 Nov 2022
Contributed by Lukas
Professor Xiao-Jun Huang discusses this Lancet Haematology series on Cellular Therapy in China, covering the history, current research challenges, and...
Glenn Pierce on haemophilia care in LMICs
30 Aug 2022
Contributed by Lukas
Dr Glenn Pierce discusses the World Federation of Hemophilia’s Humanitarian Aid Program which provides access to haemophilia care in low-income and ...
Amy DeZern on the link between myelodysplastic syndrome and autoimmune disorders
30 Jun 2022
Contributed by Lukas
Dr Amy DeZern discusses the link between myelodysplastic syndrome and autoimmune disorders and the need for a multidisciplinary approach for the treat...
Nicholas Crombie and Gavin Perkins on resuscitation with blood products compared with saline
07 Mar 2022
Contributed by Lukas
Dr Nicholas Crombie and Professor Gavin Perkins discuss their randomised phase 3 trial in which they investigated resuscitation with blood products co...
Fredrik Schjesvold on OCEAN phase 3
31 Jan 2022
Contributed by Lukas
Dr Fredrik Schjesvold discusses the results of the OCEAN phase 3 trial testing melflufen or pomalidomide plus dexamethasone for patients with multiple...
Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia
25 Nov 2021
Contributed by Lukas
Dr Jacob D Soumerai and Prof Andrew D Zelenetz discuss their phase 2 trial of the BOVen regimen and MRD-driven treatment discontinuation in previously...
Raul Cordoba on haematological malignancies in older people
03 Nov 2021
Contributed by Lukas
Dr Raul Cordoba discusses the joint Series between The Lancet Healthy Longevity and The Lancet Haematology on haematological malignancies in older peo...
Obiageli Nnodu and Dennis Chao on child mortality from sickle cell disease in Nigeria
21 Sep 2021
Contributed by Lukas
Professor Obiageli Nnodu and Dr Dennis Chao join acting Deputy Editor Emma Cookson to talk about their new study describing modelling of child mortali...
Zuguo Mei and Gary Brittenham on iron deficiency
27 Jul 2021
Contributed by Lukas
Senior Assistant Editor Ben Burwood speaks with Dr Zuguo Mei (Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disea...
Eugenia Trigoso Arjona (in English) on nursing and haematological care
11 May 2021
Contributed by Lukas
To mark International Nurses Day, Eugenia Trigoso Arjona, nurse coordinator at Hospital La Fe (Valencia, Spain) and chair of the European Society for ...
Eugenia Trigoso Arjona (in Spanish) on nursing and haematological care
11 May 2021
Contributed by Lukas
Para el Día International de la Enfermera, Eugenia Trigoso Arjona, enfermera coordinadora en el Hospital La Fe (Valencia, España) y presidenta del c...
Nada Hamad on inclusion and diversity in haematology
23 Feb 2021
Contributed by Lukas
A/Prof Nada Hamad (St Vincent’s hospital, Sydney, Australia) joins Editor-in-Chief Dr Lan-Lan Smith to discuss inclusion and diversity in haematolog...
Dr Judith Boer on lymphoblastic leukaemia in children
22 Dec 2020
Contributed by Lukas
Editor-in-Chief, Dr Lan-Lan Smith, speaks with Dr Judith Boer (Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands) about outcome...